Beringea
ActiveOverview
Beringea is a transatlantic venture capital firm founded in 1988 that provides growth-oriented capital and operational support to rapidly scaling entrepreneurial companies across the U.K., Europe, and the U.S. The firm manages institutional and private capital from offices in London and Detroit, focusing on Series A, Series B, growth, and later-stage investments with an emphasis on follow-on capital and facilitating international expansion through its transatlantic network.
History
Beringea was founded in 1988 as a Michigan-based venture capital firm. The company has undergone several name changes throughout its history, previously operating as Guinness Peat (Medical Preparations) Limited, Guinness Mahon Development Capital Limited, and Proven Private Equity Limited before adopting the Beringea name in 2003. Over three decades of investing, the firm has developed expertise across multiple sectors and established a significant presence in both the U.S. and U.K. markets.
Product Lines
| Product Line | Positioning | Price Range |
|---|---|---|
| Series A & B Investments | Early-stage growth capital for entrepreneurial companies | Varies by fund |
| Growth Stage Investments | Capital for rapidly scaling businesses | Varies by fund |
| Later-Stage Investments | Follow-on capital for mature portfolio companies | Varies by fund |
| Transatlantic Expansion Support | Operational support and network access for international growth | Included with investment |
Manufacturing
As a venture capital firm, Beringea does not manufacture physical products. The firm provides capital and operational support to portfolio companies across diverse sectors.
Notable Products
- Michigan Growth Capital Partners IV - A closed fund established in October 2021 providing growth capital to Michigan-based and regional companies
- Transatlantic Investment Network - Integrated investment and operational support platform connecting U.S. and U.K. entrepreneurs with capital and expertise
- Portfolio Company Support Services - Operational guidance and strategic support provided to portfolio companies to facilitate scaling and international expansion
Reputation
Beringea is recognized as an established transatlantic venture capital investor with three decades of experience across multiple sectors. The firm is positioned as a patient capital provider focused on supporting entrepreneurs through growth stages rather than pursuing rapid exits. Its dual-office structure and transatlantic network are viewed as distinctive advantages for companies seeking international expansion, though specific performance metrics and investor returns are not widely publicized in available sources.